Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cellular Senescence
100%
HepG2 Cells
100%
Hepatotoxic
100%
Senescence
87%
Humanized Liver
70%
Liver
58%
Toxic Metabolites
58%
Primary Hepatocytes
50%
Hepatocytes
45%
Three-dimensional Culture
41%
Silent Information Regulator 1 (SIRT1)
41%
Copyright
33%
Liver Disease
29%
Metabolic Function
29%
Human Use
29%
Resveratrol
29%
Ki67 Staining
29%
Pre-incubation
29%
Population Aging
29%
Thymidine Analogs
29%
Urea
29%
Two Dimensional
29%
Cell Population
29%
Bridge to Recovery
29%
Small Molecules
29%
Tissue Culture System
29%
Liver Transplantation
29%
Differential Capacity
29%
Albumin
29%
Rapid Failure
29%
Liver Function
29%
Alginate
29%
Ammonia
29%
Liver Dysfunction
29%
Cryogel
29%
Bridge to Transplantation
29%
Unconjugated Bilirubin
29%
D-dimensional
25%
In Vivo Metabolites
16%
Dihydroresveratrol
16%
Cell Senescence
16%
Patient Plasma
12%
HepG2
12%
Culture Surface
12%
Urea Synthesis
12%
Artificial Organs
12%
Clinical Endpoints
12%
Growth Fraction
12%
β-Galactosidase (β-Gal)
12%
Senescence-associated
12%
Medicine and Dentistry
Cellular Senescence
100%
Metabolite
100%
Liver Toxicity
100%
Bioartificial Liver
45%
Hepatocyte
28%
Sirtuin1
26%
Albumin
26%
Cytokine
26%
Liver Disease
18%
Liver Function
18%
Liver Transplantation
18%
Thymidine
18%
Liver Dysfunction
18%
Cell Population
18%
Bilirubin
18%
Ex Vivo
18%
Resveratrol
18%
Alginic Acid
18%
Urea
18%
P16
8%
Urea Cycle
8%
Artificial Organ
8%
Clinical Endpoint
8%
Protein P53
8%
Liver Failure
8%
P21
8%
Galactosidase
8%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatotoxicity
100%
Cytokine
26%
Albumin
26%
Urea
26%
Liver Dysfunction
18%
Thymidine
18%
Resveratrol
18%
Liver Disease
18%
Bilirubin
18%
Alginic Acid
18%
Protein P53
8%
Galactosidase
8%
Liver Failure
8%
Hepatotoxin
8%